Psychiatry

Biotech News

Seaport Therapeutics IPO Raises $260M for Neuropsychiatry Pipeline
Biotech Blogs

World Schizophrenia Day 2026: New Data, Tests & Treatment Targets
Biotech Blogs

What Psychedelic Clinical Trials Could Teach Psychiatry

Neuroscience Drug Development: How Novel Applications of AI Could Meaningfully Disrupt Traditional Development Strategies

May 13, 2026

How Objective Sleep Biomarkers Improve Clinical Development and Clinical Assessment in Depression

April 28, 2026
Approvals News

Bysanti FDA Approval for Bipolar I and Schizophrenia Marks Vanda’s Second Win in Two Months

Enhancing Signal Detection and Mitigating Placebo Response in Major Depressive Disorder Clinical Trials

January 27, 2026
Biotech News

MapLight Therapeutics Raises $296M in IPO to Advance CNS Drug Pipeline
Biotech News

LB Pharmaceuticals IPO Raises $285M to Advance Late-Stage Neuropsychiatry Pipeline

PANSS Update: Collaborations & New Solutions

December 09, 2025

Deconstructing OCD Through the Use of Multiple Operant Behavioral Tasks in Rodents

November 03, 2025

Advancing Psychedelic Compounds: From Preclinical Discovery to Translational Insight

July 31, 2025

Progressing Beyond Exploratory Endpoints: The Value of Digital Biomarkers in Neuroscience Clinical Studies

July 15, 2025
Diagnostics News

Optive AI Gets FDA Clearance, Elevates Image Quality for Swoop Portable MRI
Biotech Blogs

World Schizophrenia Awareness Day 2025: Advances in Precision-Driven Clinical Research
Healthcare News

Ontario Brain Institute Invests $640K to Drive Innovations in Brain Health